Literature DB >> 29427746

Nanomedicine: An effective tool in cancer therapy.

Saima Aftab1, Afzal Shah2, Akhtar Nadhman1, Sevinc Kurbanoglu3, Sibel Aysıl Ozkan3, Dionysios D Dionysiou4, Shyam S Shukla5, Tejraj M Aminabhavi6.   

Abstract

Various types of nanoparticles (NPs) have been used in delivering anticancer drugs to the site of action. This area has become more attractive in recent years due to optimal size and negligible undesirable side effects caused by the NPs. The focus of this review is to explore various types of NPs and their surface/chemical modifications as well as attachment of targeting ligands for tuning their properties in order to facilitate targeted delivery to the cancer sites in a rate-controlled manner. Heme compatibility, biodistribution, longer circulation time, hydrophilic lipophilic balance for high bioavailability, prevention of drug degradation and leakage are important in transporting drugs to the targeted cancer sites. The review discusses advantages of polymeric, magnetic, gold, and mesoporous silica NPs in delivering chemotherapeutic agents over the conventional dosage formulations along with their shortcomings/risks and possible solutions/alternatives.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood brain barrier; Cancer therapy; Controlled release; Nanomedicine; Targeted drug delivery

Mesh:

Substances:

Year:  2018        PMID: 29427746     DOI: 10.1016/j.ijpharm.2018.02.007

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  37 in total

1.  BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications.

Authors:  Jooeun Bae; Neha Parayath; Wenxue Ma; Mansoor Amiji; Nikhil Munshi; Kenneth C Anderson
Journal:  Leukemia       Date:  2019-08-19       Impact factor: 11.528

Review 2.  Why should radiation oncology do translational research? [corrected].

Authors:  Rut Cañas; Isabel Linares; Ferran Guedea; Miguel Ángel Berenguer
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-12

3.  Conventional Nanosized Drug Delivery Systems for Cancer Applications.

Authors:  Cristian Vergallo; Muhammad Nadeem Hafeez; Dalila Iannotta; Hélder A Santos; Nicola D'Avanzo; Luciana Dini; Felisa Cilurzo; Massimo Fresta; Luisa Di Marzio; Celia Christian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Multiplex Three-Dimensional Mapping of Macromolecular Drug Distribution in the Tumor Microenvironment.

Authors:  Steve Seung-Young Lee; Vytautas P Bindokas; Stephen J Kron
Journal:  Mol Cancer Ther       Date:  2018-10-15       Impact factor: 6.261

5.  Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer.

Authors:  Zhong Wan; Fangyuan Xie; Liang Wang; Guoqing Zhang; Hai Zhang
Journal:  Int J Nanomedicine       Date:  2020-07-29

6.  Pulse-Modulated Radio-Frequency Alternating-Current-Driven Atmospheric-Pressure Glow Discharge for Continuous-Flow Synthesis of Silver Nanoparticles and Evaluation of Their Cytotoxicity toward Human Melanoma Cells.

Authors:  Anna Dzimitrowicz; Aleksandra Bielawska-Pohl; George C diCenzo; Piotr Jamroz; Jan Macioszczyk; Aleksandra Klimczak; Pawel Pohl
Journal:  Nanomaterials (Basel)       Date:  2018-06-02       Impact factor: 5.076

7.  Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1.

Authors:  Elina Kibler; Anastasia Lavrinenko; Ilya Kolesnik; Ksenia Stankevich; Evgeny Bolbasov; Valeriya Kudryavtseva; Andrey Leonov; Igor Schepetkin; Andrei Khlebnikov; Mark T Quinn; Sergei Tverdokhlebov
Journal:  Eur Polym J       Date:  2020-03-04       Impact factor: 4.598

8.  Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.

Authors:  Yi Zhong; Tao Su; Qiuxiao Shi; Yanru Feng; Ze Tao; Qiuxia Huang; Lan Li; Liqiang Hu; Shengfu Li; Hong Tan; Shan Liu; Hao Yang
Journal:  Int J Nanomedicine       Date:  2019-11-01

9.  Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.

Authors:  Yike Huang; Suya Deng; Zhining Xia; Xinxin Luo; Yi Liu; Wanjun Xu; Jingmiao Pan; Min Wang
Journal:  Int J Nanomedicine       Date:  2019-12-10

Review 10.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.